Bayer A.G.'s stock is undervalued but faces risks with declining profits & regulatory pressures. Click for my updated look at ...

Bayer Pharmaceuticals' chief operating officer said the head of the top U.S. drug regulator recently reassured industry ...

Bayer is preparing a plan to settle some of its mass lawsuits over Roundup weedkiller in Missouri, and may also seek ...

Bayer plunges as a report by Health Secretary Robert F. Kennedy Jr. is expected to single out glyphosate, the active ...

Georgia has become the second state to shield pesticide manufacturers from some lawsuits claiming that they failed to warn ...

Bayer shares jumped after the company reported better-than-expected sales and adjusted earnings for the first quarter, with ...

Bayer Q1 profit declined to $1.45 billion, but earnings and sales topped estimates as pharma growth offset crop science ...

Bayer's steady cash flows from healthcare and crop science products should enable the company to both reduce debt and service current debt levels. However, the high debt levels and slow near-term ...